Innovative Cardiovascular Company Xeltis Nominates Michel Darnaud For Election To Its Board Of Directors

ZURICH--(BUSINESS WIRE)--Xeltis, a privately-held medical device company dedicated to transforming standards of care in cardiovascular treatments, announced that its Board of Directors has nominated Michel Darnaud to stand for election at the company’s Annual Meeting of Shareholders currently scheduled for June 1, 2015. Michel Darnaud is a medical device veteran with more than 30 years in leadership roles at major cardiovascular device companies.